Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos, sex toys and adult toys.
Popular Articles

Sleep Helps Build Long-Term Memories - Picower Institute Study Strengthens Link Between Sleep, Memory Formation
Experts have long suspected that part of the process of turning fleeting short-term memories into lasting long-term memories occurs during sleep. Now, researchers at the RIKEN-MIT Center for Neural Circuit Genetics of MIT"s Picower Institute for Learning and Memory have shown that mice prevented from "replaying" their waking experiences while asleep do not remember them as well as mice who are able to perform this function.
buy viagra
FDA Approves NovoLog(R) Labeling Update - Increasing The Time Patients Can Use And Store NovoLog(R) In Their Pumps From Two Days To Six Days
Diabetes patients taking NovoLog® (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk announced today.[i] The previous label allowed for NovoLog® to be stored in the pump reservoir for two days. This makes NovoLog® the first and only rapid-acting insulin with this extended in-use time.
plan for health
News of the day
Textbook Chronicling Four Decades Of Alzheimer's Research
Two of the world"s leading Alzheimer"s researchers have co-edited a book critically synthesizing the major new developments in the diagnosis and treatment of Alzheimer"s disease. Building upon a 2007 Alzheimer"s disease conference held in Chile, George Perry, dean of the College of Sciences at The University of Texas at San Antonio (UTSA) and Ricardo B. Maccioni, neurology professor at The University of Chile Medical School have edited "Current Hypotheses and Research Milestones in Alzheimer"s Disease," a 254-page text written by academics and medical doctors. The book focuses on the most promising hypotheses that illuminate the path to more effective treatment.
Endocrinology

Researchers Develop Questions To Determine Risk Of HIV/AIDS Drug Resistance

Researchers from the Makerere University hospital in Uganda, the U.S. and Belgium have developed a formula, based on a set of questions, for determining HIV-positive people"s risk of treatment failure and drug resistance, according to a study recently published in the Journal of the International AIDS Society, the New York Times reports. According to the Times, most HIV-positive people in Africa rarely have access to viral load tests to determine if they are developing resistance to first-line antiretroviral drugs because the testing is expensive and complicated.The researchers questioned 496 HIV-positive people about: *How often they had taken their drugs in the past three days, the previous four weeks and since they began treatment; *If they had ever missed two days of drugs; *If they had ever paid for treatment; *Whether women had ever taken nevirapine to prevent mother-to-child transmission; and *If the patients had experienced weight loss or rashes. The researchers also took blood samples to determine the participants" CD4+ T cell counts. They found that having ever missed treatment for two days or a 30% decrease in CD4+ count predicted treatment failure. The researchers said that viral load testing, when available, be given to these patients first. In addition, the Times reports that the new method appears to work better than World Health Organization guidelines, which are based on clinical signs of HIV progression and CD4+ counts (McNeil, New York Times, 5/18). The study is available online. Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009